Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion type Assertion NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_head.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion evidence source_evidence_literature NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion SIO_000772 20652941 NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion wasDerivedFrom befree-2016 NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.
- NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_assertion wasGeneratedBy ECO_0000203 NP827814.RAM6hb3n92cq6p4GihVILOhjgWG1eODC31Ts1QRJxhTNw130_provenance.